Dose optimization strategies for abemaciclib: insights from the TRADE trial.

Nogueira LR, Bianchi MA, Ciruelos E

Open source

DOI
10.21037/tbcr-2026-0034
Published
2026
Container
Translational breast cancer research : a journal focusing on translational research in breast cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tbcr-2026-0034,
  title = {Dose optimization strategies for abemaciclib: insights from the TRADE trial.},
  author = {Nogueira LR and Bianchi MA and Ciruelos E},
  year = {2026},
  journal = {Translational breast cancer research : a journal focusing on translational research in breast cancer},
  doi = {10.21037/tbcr-2026-0034},
  url = {https://doi.org/10.21037/tbcr-2026-0034}
}

RIS

TY  - JOUR
TI  - Dose optimization strategies for abemaciclib: insights from the TRADE trial.
AU  - Nogueira LR
AU  - Bianchi MA
AU  - Ciruelos E
PY  - 2026
JO  - Translational breast cancer research : a journal focusing on translational research in breast cancer
DO  - 10.21037/tbcr-2026-0034
UR  - https://doi.org/10.21037/tbcr-2026-0034
ER  - 

APA

LR, N., MA, B., & E, C. (2026). Dose optimization strategies for abemaciclib: insights from the TRADE trial.. Translational breast cancer research : a journal focusing on translational research in breast cancer. https://doi.org/10.21037/tbcr-2026-0034

Source records